BSEOthers1 Sept 2026 · 1 Sept 2026, 04:04 pm

We hereby informed that Board of Directors of the Company at its meeting held on Tuesday, the 01st September, 2026 discuss the agenda attached herewith.

iSERA Lifesciences Ltd · 534920

✦ AI SummaryResults

iSERA Lifesciences Ltd has informed about the outcome of its Board Meeting held on September 1, 2026, where the Board approved the notice for the 34th Annual General Meeting, audited standalone financial statements for FY 2025-26, and the Annual Report for FY 2025-26.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

iSERA Lifesciences Ltd - 534920 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 01.09.2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

40ff1656-710f-41b0-9b18-e884c38f5f14.pdf

pdf

Download →
View document text
iSERA LIFESCIENCES LIMITED iSERA R . (For ly knowna s Goxidh. Te L d) CIN: 172200PN Date: 01.09.2026 The Secretary Department Of Corporate Services Bombay Stock Exchange Limited Floor 25, Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai-400 oo1 BSE Scrip Code: 534920 Subject: Outcome of the Board Meeting held today on 01.09.2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the Board of Directors of the Company at its meeting held on Tuesday, the o1t September, 2026 held via video conferencing which commenced at 3.30 P.M. and concluded at 04:00 P.M. consider and approve: 1. Fixed the day, date, time and mode, and approved the Notice to be sent to the members of the Company and the Stock Exchange for convening the 34th Annual General Meeting of the Company for the Financial Year 2025-26, scheduled to be held on Tuesday, September 29, 2026, at 3 P.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”), to receive, consider and adopt the audited standalone financial statements of the company for the financial year ended 31st march, 2026, and the reports of the board of director’s and auditor’s thereon; 2. The Annual Report of the Company for the Financial Year 2025-26, including the Director’s Report and its Annexures, for the financial year ended 31st March, 2026. 3. The appointment of Scrutinizer for the Annual General Meeting of the Company; M/s. Anuj Gupta & Associates, Company Secretaries, have been appointed as the Scrutinizer for remote e-voting/e-voting at the time of 34t Annual General Meeting of the Company. You are requested to take the above information on records. Thanking you, Yours faithfully, Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune — 411001 Tel: 4918329012053 + Email: cscovidh@gmail.com + Website: www.covidhtechnologies.com iSERA LIFESCIENCES LIMITED CIN: L72200PN1993PLC252720 On the behalf of the Board of Directors iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) Company Secretary Cum Compliance Officer Deepakshi MEM. NO.: A76335 Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pu— 4n110e01 Tel: 4918329012053 + Email: cscovidh@gmail.com + Website: www.covidhtechnologies.com